Article thumbnail
Location of Repository

Inhibitory Effect of Herbal Remedy PERVIVO and Anti-Inflammatory Drug Sulindac on L-1 Sarcoma Tumor Growth and Tumor Angiogenesis in Balb/c Mice

By P. Skopiński, B. J. Bałan, J. Kocik, R. Zdanowski, S. Lewicki, M. Niemcewicz, K. Gawrychowski, E. Skopińska-Różewska and W. Stankiewicz

Abstract

Anticancer activity of many herbs was observed for hundreds of years. They act as modifiers of biologic response, and their effectiveness may be increased by combining multiple herbal extracts . PERVIVO, traditional digestive herbal remedy, contains some of them, and we previously described its antiangiogenic activity. Numerous studies documented anticancer effects of nonsteroidal anti-inflammatory drugs. We were the first to show that sulindac and its metabolites inhibit angiogenesis. In the present paper the combined in vivo effect of multicomponent herbal remedy PERVIVO and nonsteroidal anti-inflammatory drug sulindac on tumor growth, tumor angiogenesis, and tumor volume in Balb/c mice was studied. These effects were checked after grafting cells collected from syngeneic sarcoma L-1 tumors into mice skin. The strongest inhibitory effect was observed in experimental groups treated with PERVIVO and sulindac together. The results of our investigation showed that combined effect of examined drugs may be the best way to get the strongest antiangiogenic and antitumor effect

Topics: Pathology, RB1-214
Publisher: Hindawi Limited
Year: 2013
DOI identifier: 10.1155/2013
OAI identifier: oai:doaj.org/article:ef65a0848cdd4a3fb26ddcf774d15c38
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1466-1861 (external link)
  • https://doaj.org/toc/0962-9351 (external link)
  • http://dx.doi.org/10.1155/2013... (external link)
  • https://doaj.org/article/ef65a... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.